Published in J Natl Cancer Inst on June 01, 1972
The relation of infection with the hepatitis B agent to primary hepatic carcinoma. Am J Pathol (1975) 2.39
Recent advances in the study of the epidemiology of hepatitis B. Am J Pathol (1975) 1.64
Sex differences in response to hepatitis B infection among patients receiving chronic dialysis treatment. Proc Natl Acad Sci U S A (1977) 0.97
The modulation of apoptosis by oncogenic viruses. Virol J (2013) 0.89
Immunological studies in Ugandan patients with hepatocellular carcinoma. Br Med J (1973) 0.89
Geographic correlation between mortality from primary hepatic carcinoma and prevalence of hepatitis B surface antigen in Greece. Br J Cancer (1976) 0.86
Primary hepatocellular carcinoma and IgG heavy chain allotypes. Clin Exp Immunol (1983) 0.85
Primary carcinoma of the liver. Ann R Coll Surg Engl (1976) 0.75
Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol (1999) 11.78
Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) (1970) 5.98
Antibody to hepatitis-B-virus core in man. Lancet (1973) 4.24
Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation. Science (1969) 3.98
Class C Vps protein complex regulates vacuolar SNARE pairing and is required for vesicle docking/fusion. Mol Cell (2000) 3.30
Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther (2012) 3.25
Estimates of the half-life of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Vietnam Veterans of Operation Ranch Hand. J Toxicol Environ Health (1989) 3.06
Elastic vascular sclerosis of mesenteric blood vessels in argentaffin carcinoma. J Clin Pathol (1970) 2.94
Transmission of type B viral hepatitis to chimpanzees. J Infect Dis (1973) 2.51
Experimental infection of chimpanzees with hepatitis A virus. J Infect Dis (1975) 2.41
Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc Natl Acad Sci U S A (1999) 2.25
A role for synaptotagmin (p65) in regulated exocytosis. Cell (1993) 2.22
The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol (1978) 2.13
Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma. Lancet (1970) 2.11
Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer. J Clin Oncol (2001) 2.11
The pathology of frozen shoulder. A Dupuytren-like disease. J Bone Joint Surg Br (1995) 2.10
Kaposi's sarcoma in Uganda: a clinico-pathological study. Int J Cancer (1971) 2.06
Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication. N Engl J Med (1974) 1.98
Achalasia of the cardia: pharmacology and histopathology of isolated cardiac sphincteric muscle from patients with and without achalasia. Q J Med (1969) 1.97
Transmission of serum hepatitis. JAMA (1970) 1.84
Transmission of non-A, non-B hepatitis from man to chimpanzee. Lancet (1978) 1.82
Metastatic prostatic carcinoma presenting as left-sided cervical lymphadenopathy: a series of 11 cases. Histopathology (1992) 1.69
Virus-like particles in sera of patients with infectious and serum hepatitis. JAMA (1969) 1.68
Liver cell dysplasia: a premalignant condition. J Clin Pathol (1973) 1.66
Necrotizing renal vasculopathy resulting in chronic renal failure after ingestion of methamphetamine and 3,4-methylenedioxymethamphetamine ('ecstasy') Nephrol Dial Transplant (1998) 1.64
Musculoskeletal disorders among visual display terminal users in a telecommunications company. Ergonomics (1994) 1.57
Hepatitis B virus infection in chimpanzees: titration of subtypes. J Infect Dis (1975) 1.55
Angiosarcoma of the liver: annual occurrence and aetiology in Great Britain. Br J Ind Med (1980) 1.52
Hepatitis A antigen particles in liver, bile, and stool of chimpanzees. J Infect Dis (1976) 1.51
Titration and neutralization of Rickettsia tsutsugamushi in tissue culture. J Immunol (1968) 1.51
Transmission of serum hepatitis. 1970. JAMA (1996) 1.49
Primary carcinoma of the liver: a study of 282 cases in Ugandan Africans. J Pathol (1973) 1.49
Standardized comparisons of the use of alcohol, drugs, and cigarettes among military personnel and civilians. Am J Public Health (1991) 1.45
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. J Clin Oncol (1996) 1.44
Immunological effects of BCG in malignant melanoma: two modes of administration compared. Ann Intern Med (1972) 1.43
Viral hepatitis, type B, in experimental animals. Am J Med Sci (1976) 1.41
Adenoid cystic carcinoma of the breast: prevalence, diagnostic criteria, and histogenesis. J Clin Pathol (1975) 1.39
The morphology of cirrhosis: definition, nomenclature, and classification. Bull World Health Organ (1977) 1.37
Intranuclear aggregates in the liver of a patient with serum hepatitis. Lancet (1970) 1.36
Subtyping of hepatitis B surface antigen and antibody by radioimmunoassay. Gastroenterology (1977) 1.34
Role of complement in immune inactivation of Mycoplasma gallisepticum. J Bacteriol (1967) 1.34
Asymptomatic cytomegalovirus infection following blood transfusion in tumor surgery. JAMA (1970) 1.33
Why Are B ions stable species in peptide spectra? J Am Soc Mass Spectrom (1995) 1.31
Hepatitis B core antigen: immunology and electron microscopy. J Virol (1974) 1.30
Schizophrenia and the limbic system. Lancet (1974) 1.29
Detection of antibody to hepatitis-associated antigen in hemophilia patients and in voluntary blood donors. Vox Sang (1973) 1.29
The structure and fragmentation of B n (n≥3) ions in peptide spectra. J Am Soc Mass Spectrom (1996) 1.27
Angiosarcoma of the liver in Great Britain, 1963-73. Br Med J (1977) 1.26
Some antigenic and physical properties of virus-like particles in sera of hepatitis patients. J Immunol (1969) 1.25
Transmission of non-A, non-B hepatitis. Ann Intern Med (1977) 1.25
Effect of ethanol during hepatitis B virus infection in chimpanzees. J Med Virol (1978) 1.24
Multiple and recurrent inflammatory fibroid polyps in three generations of a Devon family: a new syndrome. Gut (1984) 1.23
Antibody responses in viral hepatitis, type B. JAMA (1973) 1.23
Relationship of virus dose to incubation time of clinical hepatitis and time of appearance of hepatitis--associated antigen. Am J Med Sci (1972) 1.23
Determination of antibiotic susceptibility of Rickettsiae and Chlamydiae in BS-C-1 cell cultures. Antimicrob Agents Chemother (Bethesda) (1968) 1.21
Inflammatory pseudotumour of the liver. J Clin Pathol (1986) 1.19
Review of infectivity studies in nonhuman primates with virus-like particles associated with MS-1 hepatitis. Am J Med Sci (1976) 1.16
Kaposi's sarcoma: a comparison of classical, endemic, and epidemic forms. Semin Oncol (1984) 1.16
Failure to detect an antigen associated with hepatitis in a community epidemic. Nature (1970) 1.16
Treatment of Kaposi's sarcoma with actinomycin-D and cyclophosphamide: results of a randomized clinical trial. Int J Cancer (1971) 1.16
Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2013) 1.15
Aquisition of hepatitis-associated antigen. Clinical features in young adults. JAMA (1971) 1.15
Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial. Oncology (2002) 1.15
Immunofluorescence microscopy in experimentally induced, type B hepatitis in the chimpanzee. Gastroenterology (1978) 1.13
Hepatitis-associated antigen and cirrhosis in Uganda. Lancet (1970) 1.12
Primary lymphoma of the breast. Histopathology (1985) 1.11
Pneumocystis carinii pneumonia. Ann Intern Med (1968) 1.10
Hepatitis B virus infection and primary hepatocellular carcinoma. J Natl Cancer Inst (1977) 1.10
A review of vinorelbine in the treatment of breast cancer. Clin Breast Cancer (2001) 1.09
A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United States. Cancer (1977) 1.08
Childhood acute lymphocytic leukemia: study VIII. Cancer (1978) 1.07
Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinoma. Cancer (1976) 1.06
Familial chronic lymphocytic leukemia. Ann Intern Med (1969) 1.06
Celiac axis compression: experience with 20 patients and a critical appraisal of the syndrome. Ann Intern Med (1977) 1.05
Striate melanokeratosis following trabeculectomy with 5-fluorouracil. Arch Ophthalmol (1990) 1.05
D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour. Brain Res (1989) 1.04
Hepatitis-associated antigen and antibody in Uganda: correlation of serological testing with histopathology. Br Med J (1972) 1.04
Evaluation of an extensive tuberculosis contact investigation in an urban community and jail. Int J Tuberc Lung Dis (2003) 1.03
Production of rickettsial complement-fixing antigens in tissue culture. J Immunol (1968) 1.03
Hepatitis A antigen isolated from liver and stool: immunologic comparison of antisera prepared in guinea pigs. J Immunol (1976) 1.03
Effects of cyclophosphamide on hepatitis B virus infection and challenge in chimpanzees. J Infect Dis (1975) 1.03
Slow and latent viruses in schizophrenia. Lancet (1973) 1.02